Average Co-Inventor Count = 2.09
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (50 from 4,455 patents)
2. Lixte Biotechnology, Inc. (5 from 27 patents)
3. Pfizer Products Inc. (2 from 47 patents)
4. Debiopharm International, S.a. (2 from 20 patents)
5. Biopharma Works LLC (2 from 3 patents)
6. Biohaven Therapeutics Ltd. (1 from 29 patents)
7. Krouzon Pharmaccuticals, Inc. (1 from 1 patent)
8. Biohaven Pharmaceutical Holding Company Limited (8 patents)
9. Anthony Marfat (0 patent)
10. James Frederick Eggler (0 patent)
11. Hiroko Masamune (0 patent)
12. Lawrence Sherman Jr. Melvin (0 patent)
62 patents:
1. 11866444 - Oxabicycloheptane prodrugs
2. 11236102 - Oxabicycloheptane prodrugs
3. 11083711 - Amine prodrugs of pharmaceutical compounds
4. 10618908 - Oxabicycloheptane prodrugs
5. 10435389 - Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2
6. 10364252 - Oxabicycloheptane prodrugs
7. 10072018 - Compounds for treatment of pain
8. 10035813 - Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
9. 9988394 - Oxabicycloheptane prodrugs
10. 9487531 - Compounds for treatment of pain
11. 9180123 - N-link hydroxamic acid derivatives useful as antibacterial agents
12. 9018384 - N-link hydroxamic acid derivatives useful as antibacterial agents
13. 8901105 - Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
14. 8853258 - C-linked hydroxamic acid derivatives useful as antibacterial agents
15. 8846933 - N-link hydroxamic acid derivatives useful as antibacterial agents